Vaccines, blood, antisera, toxins and cultures in   Netherlands

Exports In 2023, Netherlands exported $25.1B in Vaccines, blood, antisera, toxins and cultures, making it the 6th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 2nd most exported product in Netherlands. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Netherlands are: United States ($9.01B), Germany ($4.88B), France ($2.84B), Italy ($1.47B), and Spain ($940M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Netherlands between 2022 and 2023 were United States ($5.09B), France ($474M), and South Korea ($302M).

Imports In 2023, Netherlands imported $12.4B in Vaccines, blood, antisera, toxins and cultures, becoming the 8th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 9th most imported product in Netherlands. Netherlands imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($3.16B), United States ($2.48B), Italy ($1.52B), Ireland ($1.1B), and Belgium ($1.02B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Netherlands between 2022 and 2023 were Denmark ($885M), Italy ($466M), and United States ($437M).

COMPANIES In 2023, leading companies such as Amazon (4) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Netherlands to the United States.